Search research articles
Contact Us
Filters
Showing results (61-70 of 162) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
October 6, 2022
Trial designs and endpoints for immune therapies in multiple myeloma
Guido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 21, 2021
Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma
Tarek H Mouhieddine, Julia Hieulle, Erin Moshier, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
July 27, 2010
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma
Renumathy Dhanasekaran, Vinit Khanna, David A Kooby, et al.
Haematologica
|
July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma
Tarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Oncotarget
|
March 6, 2020
MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21<sup>Cip1</sup>
Anna Huo-Chang Mei, Kaity Tung, Jessie Han, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
Guido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
Anthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
Siyang Leng, Erin Moshier, Douglas Tremblay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 18, 2021
Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Ajai Chari, Erika Florendo, Ines Stefania Mancia, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 162) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
October 6, 2022
Trial designs and endpoints for immune therapies in multiple myeloma
Guido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 21, 2021
Treatment Bridging With a 28-Day Metronomic Therapy (Metro-28) for Relapsed Refractory Multiple Myeloma
Tarek H Mouhieddine, Julia Hieulle, Erin Moshier, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
July 27, 2010
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma
Renumathy Dhanasekaran, Vinit Khanna, David A Kooby, et al.
Haematologica
|
July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma
Tarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 15, 2013
Phase I/II trial of nanomolecular liposomal annamycin in adult patients with relapsed/refractory acute lymphoblastic leukemia
Meir Wetzler, Debora A Thomas, Eunice S Wang, et al.
Oncotarget
|
March 6, 2020
MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21<sup>Cip1</sup>
Anna Huo-Chang Mei, Kaity Tung, Jessie Han, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple Myeloma
Guido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple Myeloma
Anthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
Siyang Leng, Erin Moshier, Douglas Tremblay, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 18, 2021
Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma
Ajai Chari, Erika Florendo, Ines Stefania Mancia, et al.
Page
of 17